California responds to Cronavirus
A building on the Gilead campus in Foster City, California is seen on Thursday, April 23, 2020. Data on Gilead's antiviral medicine remdesivir from a clinical trial in China, suggest it failed to speed the improvement of patients with Covid-19. Gilead, however, said the data, released by accident, suggest a "potential benefit." Photo by Terry Schmitt/UPI
Please fill out form for pricing information for the photo below.